ONCOtherapeutics Competitors and Similar CompaniesClear all
CEL-SCI's competitors and similar companies include Abliva.
 CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | |
Founding Date | Founding Date 1983 | Founding Date 2000 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Vienna, US HQ | Locations Lund, SE HQ |
Employees | Employees N/A | Employees 950% increase |
Financial | ||
Net income | Net income ($25.4m) (FY, 2025) | Net income (kr90m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Abliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View company